TrialClinical pharmacology in drug development2026

First-In-Human Study to Assess the Pharmacokinetics and Safety of DS-6016a After Single Subcutaneous Injection in Healthy Japanese Adults.

Kei Okita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.